105 related articles for article (PubMed ID: 2238755)
1. [Effect of pancreatin on diabetes mellitus in chronic pancreatitis].
Glasbrenner B; Malfertheiner P; Kerner W; Scherbaum WA; Ditschuneit H
Z Gastroenterol; 1990 Jun; 28(6):275-9. PubMed ID: 2238755
[TBL] [Abstract][Full Text] [Related]
2. Diabetes mellitus secondary to chronic pancreatitis.
Larsen S
Dan Med Bull; 1993 Apr; 40(2):153-62. PubMed ID: 8495594
[TBL] [Abstract][Full Text] [Related]
3. Elevated plasma levels of glucagon-like peptide-1 after oral glucose ingestion in patients with pancreatic diabetes.
Hiroyoshi M; Tateishi K; Yasunami Y; Maeshiro K; Ono J; Matsuoka Y; Ikeda S
Am J Gastroenterol; 1999 Apr; 94(4):976-81. PubMed ID: 10201468
[TBL] [Abstract][Full Text] [Related]
4. [Significance of pancreatic polypeptide in gastrointestinal diseases].
Petritsch W; Leb G; Pristautz H
Acta Med Austriaca; 1985; 12(5):139-43. PubMed ID: 3832746
[TBL] [Abstract][Full Text] [Related]
5. [Secondary diabetes in chronic pancreatitis].
Raue G; Keim V
Z Gastroenterol; 1999 Jun; Suppl 1():4-9. PubMed ID: 10444809
[TBL] [Abstract][Full Text] [Related]
6. [Peculiarities of diabetes mellitus course in chronic pancreatitis].
Vinokurova LV; Drozdov VN; Berezina OI; Shuliat'ev IS; Varvanina GG; Nemezhinskiĭ VI
Eksp Klin Gastroenterol; 2011; (7):59-63. PubMed ID: 22364001
[TBL] [Abstract][Full Text] [Related]
7. Comparison of different endocrine stimulation tests in nondiabetic patients with chronic pancreatitis.
von Tirpitz C; Glasbrenner B; Mayer D; Malfertheiner P; Adler G
Hepatogastroenterology; 1998; 45(22):1111-6. PubMed ID: 9756016
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic polypeptide secretion in diabetic patients with idiopathic haemochromatosis.
Lassmann V; Passa P; Vague P; Vialettes B
Diabete Metab; 1987 Apr; 13(2):106-9. PubMed ID: 3595966
[TBL] [Abstract][Full Text] [Related]
9. [Effect of acarbose on postprandial increase in blood glucose. Additive acute effect of once daily administration in insulin treated diabetes].
Ledermann H; Höxter G
Fortschr Med; 1994 Nov; 112(32):467-70. PubMed ID: 7821886
[TBL] [Abstract][Full Text] [Related]
10. [Diabetes mellitus in patients with chronic alcoholic pancreatitis].
Sadokov VM; Vinokurova LV
Ter Arkh; 1993; 65(10):27-9. PubMed ID: 8296228
[TBL] [Abstract][Full Text] [Related]
11. Effects of acetylsalicylic acid on blood glucose, plasma FFA, glycerol, 3-hydroxybutyrate, alanine, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetics.
Giugliano D; Luyckx AS; Lefebvre PJ
Diabete Metab; 1980 Mar; 6(1):39-46. PubMed ID: 6989660
[TBL] [Abstract][Full Text] [Related]
12. C-peptide pattern in patients with pancreatic cancer.
Fogar P; Basso D; Panozzo MP; Del Favero G; Briani G; Fabris C; D'Angeli F; Meggiato T; Ferrara C; Plebani M
Anticancer Res; 1993; 13(6B):2577-80. PubMed ID: 8135497
[TBL] [Abstract][Full Text] [Related]
13. Minimal influence of the time interval between injection of regular insulin and food intake on blood glucose control of type 1 diabetic patients on a basal-bolus insulin scheme.
Scheen AJ; Letiexhe MR; Lefèbvre PJ
Diabetes Metab; 1999 Jun; 25(2):157-62. PubMed ID: 10443327
[TBL] [Abstract][Full Text] [Related]
14. The insulinotropic effect of GIP is impaired in patients with chronic pancreatitis and secondary diabetes mellitus as compared to patients with chronic pancreatitis and normal glucose tolerance.
Knop FK; Vilsbøll T; Højberg PV; Larsen S; Madsbad S; Holst JJ; Krarup T
Regul Pept; 2007 Dec; 144(1-3):123-30. PubMed ID: 17692937
[TBL] [Abstract][Full Text] [Related]
15. Effects of the dipeptidyl peptidase-IV inhibitor vildagliptin on incretin hormones, islet function, and postprandial glycemia in subjects with impaired glucose tolerance.
Rosenstock J; Foley JE; Rendell M; Landin-Olsson M; Holst JJ; Deacon CF; Rochotte E; Baron MA
Diabetes Care; 2008 Jan; 31(1):30-5. PubMed ID: 17947341
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic polypeptide administration improves abnormal glucose metabolism in patients with chronic pancreatitis.
Brunicardi FC; Chaiken RL; Ryan AS; Seymour NE; Hoffmann JA; Lebovitz HE; Chance RE; Gingerich RL; Andersen DK; Elahi D
J Clin Endocrinol Metab; 1996 Oct; 81(10):3566-72. PubMed ID: 8855802
[TBL] [Abstract][Full Text] [Related]
17. TRH-immunoreactivity in chronic pancreatitis.
Duntas L; Glasbrenner B; Wolf C; Pieramico O; Büchler M; Malfertheiner P
Hepatogastroenterology; 1992 Oct; 39(5):413-6. PubMed ID: 1459520
[TBL] [Abstract][Full Text] [Related]
18. [Hormonal mechanisms of carbohydrate metabolism disorders in chronic pancreatitis].
Iakhontova OI; Pomazovskaia VA
Ter Arkh; 1991; 63(2):55-8. PubMed ID: 2048024
[TBL] [Abstract][Full Text] [Related]
19. The exacerbation of pancreatic endocrine dysfunction by potent pancreatic exocrine supplements in patients with chronic pancreatitis.
O'Keefe SJ; Cariem AK; Levy M
J Clin Gastroenterol; 2001 Apr; 32(4):319-23. PubMed ID: 11276275
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic hormone secretion in chronic pancreatitis without residual beta-cell function.
Larsen S; Hilsted J; Tronier B; Worning H
Acta Endocrinol (Copenh); 1988 Jul; 118(3):357-64. PubMed ID: 2899369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
